Recent Finacing
Recent Raise
Degron Therapeutics is a clinical-stage biotechnology company discovering and developing molecular glue degraders using its GlueXplorer® discovery platform.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
